down arrow

Chimin Health Management Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002193
CNY
9.29
-0.4 (-4.13%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

5.2215.10
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Net Sales has grown by an annual rate of -1.80% and Operating profit at -232.73% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 4.40% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -1.80% and Operating profit at -232.73% over the last 5 years

 
3

The company has declared negative results for the last 2 consecutive quarters

4

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 6,334 Million (Mid Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

-9.61%

stock-summary
Price to Book

4.45

Revenue and Profits:
Net Sales:
181 Million
(Quarterly Results - Jun 2025)
Net Profit:
-38 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.27%
0%
-11.27%
6 Months
48.4%
0%
48.4%
1 Year
15.4%
0%
15.4%
2 Years
2.09%
0%
2.09%
3 Years
-2.21%
0%
-2.21%
4 Years
-9.05%
0%
-9.05%
5 Years
-69.17%
0%
-69.17%

Chimin Health Management Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Chimin Health Management Hits Day High with 6.3% Intraday Surge

Chimin Health Management Hits Day High with 6.3% Intraday Surge

Chimin Health Management Co., Ltd. saw a notable intraday increase on October 15, 2025, contrasting with a decline in the China Shanghai Composite. While the stock has gained significantly over the year, it faces challenges with a negative return on equity and a cautious financial outlook.

Read More
Chimin Health Management Hits Day Low at CNY 9.97 Amid Price Pressure

Chimin Health Management Hits Day Low at CNY 9.97 Amid Price Pressure

Chimin Health Management Co., Ltd. faced a notable stock decline amid ongoing challenges, including poor quarterly results and a significant drop in net sales. The company's financial metrics reveal low profitability and high financial risk, contributing to its recent stock performance struggles despite a positive year-to-date trend.

Read More
Chimin Health Management Hits Day Low at CNY 10.03 Amid Price Pressure

Chimin Health Management Hits Day Low at CNY 10.03 Amid Price Pressure

Chimin Health Management Co., Ltd. faced a notable stock decline on October 13, 2025, amid ongoing challenges, including a decrease in net sales and significant drops in operating profit. Despite a yearly increase, the company has reported negative results for the past two quarters, raising concerns among investors.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.80%
EBIT Growth (5y)
-232.73%
EBIT to Interest (avg)
0.94
Debt to EBITDA (avg)
6.88
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.39
Tax Ratio
14.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.98%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.45
EV to EBIT
-47.62
EV to EBITDA
-334.97
EV to Capital Employed
3.77
EV to Sales
10.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.92%
ROE (Latest)
-9.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.63% vs 98.44% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -224.79% vs 86.93% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "181.30",
          "val2": "178.40",
          "chgp": "1.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.90",
          "val2": "19.10",
          "chgp": "-151.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.80",
          "val2": "5.90",
          "chgp": "-1.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-38.00",
          "val2": "-11.70",
          "chgp": "-224.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-217.80%",
          "val2": "-58.80%",
          "chgp": "-15.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -13.50% vs 6.94% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -14.02% vs -288.51% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "763.70",
          "val2": "882.90",
          "chgp": "-13.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.30",
          "val2": "151.90",
          "chgp": "-53.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "21.70",
          "val2": "23.80",
          "chgp": "-8.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.60",
          "val2": "-79.20",
          "chgp": "97.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-56.10",
          "val2": "-49.20",
          "chgp": "-14.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-65.70%",
          "val2": "48.00%",
          "chgp": "-11.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
181.30
178.40
1.63%
Operating Profit (PBDIT) excl Other Income
-9.90
19.10
-151.83%
Interest
5.80
5.90
-1.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-38.00
-11.70
-224.79%
Operating Profit Margin (Excl OI)
-217.80%
-58.80%
-15.90%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.63% vs 98.44% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -224.79% vs 86.93% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
763.70
882.90
-13.50%
Operating Profit (PBDIT) excl Other Income
70.30
151.90
-53.72%
Interest
21.70
23.80
-8.82%
Exceptional Items
-1.60
-79.20
97.98%
Consolidate Net Profit
-56.10
-49.20
-14.02%
Operating Profit Margin (Excl OI)
-65.70%
48.00%
-11.37%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -13.50% vs 6.94% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -14.02% vs -288.51% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Chimin Health Management Co., Ltd. stock-summary
stock-summary
Chimin Health Management Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."